Literature DB >> 20537626

Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial.

Alessandro Pacchiarotti1, Marco Sbracia, Antonio Frega, Helmy Selman, Leonardo Rinaldi, Arianna Pacchiarotti.   

Abstract

To compare IVF outcome in ovarian stimulation protocols with recombinant FSH plus recombinant LH versus hMG, 122 patients were randomized into two study groups: group A, patients treated with urinary hMG, and group B, patients treated with rFSH plus rLH. The two groups proved to be comparable to the main IVF outcome (pregnancy rate, implantation rate, oocytes, and embryos quality), with an increasing risk of ovarian hyperstimulation in the Pergoveris group.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20537626     DOI： 10.1016/j.fertnstert.2010.04.035

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  20 in total

1.  Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study.

Authors:  Alberto Revelli; Alessandra Chiado'; Daniela Guidetti; Francesca Bongioanni; Valentina Rovei; Gianluca Gennarelli
Journal:  J Assist Reprod Genet       Date:  2012-05-29       Impact factor: 3.412

2.  Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve.

Authors:  Mario Mignini Renzini; Claudio Brigante; Giovanni Coticchio; Mariabeatrice Dal Canto; Ilaria Caliari; Ruggero Comi; Elena De Ponti; Rubens Fadini
Journal:  J Assist Reprod Genet       Date:  2017-09-04       Impact factor: 3.412

3.  Effects of urinary and recombinant gonadotropins on in vitro maturation outcomes of mouse preantral follicles.

Authors:  Kyung Eui Park; Seung-Yup Ku; Kyung Cheon Jung; Hung Ching Liu; Yoon Young Kim; Yong Jin Kim; Seok Hyun Kim; Young Min Choi; Jung Gu Kim; Shin Yong Moon
Journal:  Reprod Sci       Date:  2012-12-13       Impact factor: 3.060

4.  Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.

Authors:  Alberto Revelli; Grazia Pettinau; Gemma Basso; Andrea Carosso; Alessandro Ferrero; Cecilia Dallan; Stefano Canosa; Gianluca Gennarelli; Daniela Guidetti; Claudia Filippini; Chiara Benedetto
Journal:  Reprod Biol Endocrinol       Date:  2015-07-25       Impact factor: 5.211

Review 5.  Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

Authors:  Rogério de Barros F Leão; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 6.  Gonadotrophins: The future.

Authors:  Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2014 Oct-Dec

Review 7.  Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency.

Authors:  Leonardo Rinaldi; Helmy Selman
Journal:  Int J Womens Health       Date:  2016-05-25

8.  Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.

Authors:  Jaro Wex; Ahmed M Abou-Setta
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-09

9.  Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.

Authors:  Antonio Requena; María Cruz; Francisco J Ruiz; Juan A García-Velasco
Journal:  Reprod Biol Endocrinol       Date:  2014-01-29       Impact factor: 5.211

10.  Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.

Authors:  Raoul Orvieto; Christos A Venetis; Human M Fatemi; Thomas D'Hooghe; Robert Fischer; Yulia Koloda; Marcos Horton; Michael Grynberg; Salvatore Longobardi; Sandro C Esteves; Sesh K Sunkara; Yuan Li; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.